ANTONIO
OSUNA ORTEGA
COLABORADOR EXTRAORDINARIO
Novartis (Sweden)
Täby, SueciaNovartis (Sweden)-ko ikertzaileekin lankidetzan egindako argitalpenak (1)
2019
-
Safety of everolimus with reduced calcineurin inhibitor exposure in de novo kidney transplants: An analysis from the randomized transform study
Transplantation, Vol. 103, Núm. 9, pp. 1953-1963